Pub. Date : 2012 Apr
PMID : 21046425
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Vandetanib is an orally active small molecule tyrosine kinase inhibitor (TKI) with activity against several pathways implicated in malignancy including the vascular endothelial growth factor receptor pathway, the epidermal growth factor receptor pathway, the platelet derived growth factor receptor beta pathway, and REarranged during Transfection pathway. | vandetanib | platelet derived growth factor receptor beta | Homo sapiens |